Adherence,persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetate
1. Multiple Sclerosis Center of Atlanta, Atlanta, GA, USA;2. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;3. Optum, Eden Prairie, MN, USA;4. University of Maryland School of Pharmacy, Baltimore, MD, USA